Antibody News and Research

RSS
An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Further Reading

Phase 1 clinical trial of vaccine for rare but deadly mosquito-borne viruses shows promising results

Phase 1 clinical trial of vaccine for rare but deadly mosquito-borne viruses shows promising results

Phase 1 trial of COVID-19 PTXCOVID19-B vaccine

Phase 1 trial of COVID-19 PTXCOVID19-B vaccine

Clonality and magnitude of SARS-CoV-2-reactive CD4+ T cells in COVID-19 convalescent patients after vaccination

Clonality and magnitude of SARS-CoV-2-reactive CD4+ T cells in COVID-19 convalescent patients after vaccination

Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

SK bioscience's typhoid vaccine licensed for export by Korean Ministry of Food and Drug Safety

SK bioscience's typhoid vaccine licensed for export by Korean Ministry of Food and Drug Safety

Imprinted antibody responses towards SARS-CoV-2 Omicron subvariants

Imprinted antibody responses towards SARS-CoV-2 Omicron subvariants

Study shows reduced respiratory syncytial virus antibody levels in women of childbearing age and infants during the COVID-19 pandemic

Study shows reduced respiratory syncytial virus antibody levels in women of childbearing age and infants during the COVID-19 pandemic

Messenger RNA COVID-19 vaccines induce high levels of short-lived antibodies compared to natural infection

Messenger RNA COVID-19 vaccines induce high levels of short-lived antibodies compared to natural infection

Researchers Identify Potential Target for Rhabdomyosarcoma Recurrence Prevention

Researchers Identify Potential Target for Rhabdomyosarcoma Recurrence Prevention

Research looks at potential of pantethine against SARS-CoV-2

Research looks at potential of pantethine against SARS-CoV-2

SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

The promise of RNA medicine is targeted and personalized

The promise of RNA medicine is targeted and personalized

Study shows efficacy of COVID-19 vaccine in people receiving cancer treatment

Study shows efficacy of COVID-19 vaccine in people receiving cancer treatment

Children exposed to maltreatment present a response-to-stress pattern like that of adolescents

Children exposed to maltreatment present a response-to-stress pattern like that of adolescents

Effectiveness of COVID-19 monoclonal antibodies against SARS-CoV-2 Omicron variant

Effectiveness of COVID-19 monoclonal antibodies against SARS-CoV-2 Omicron variant

Vaccine features that could induce durable humoral immune responses against SARS-CoV-2

Vaccine features that could induce durable humoral immune responses against SARS-CoV-2

Susceptibility of four SARS-CoV-2 Omicron sub-lineages to vaccines and monoclonal antibodies

Susceptibility of four SARS-CoV-2 Omicron sub-lineages to vaccines and monoclonal antibodies

Study investigates antibody-mediated response against different SARS-CoV-2 variants

Study investigates antibody-mediated response against different SARS-CoV-2 variants

Decoy ACE2 nanoparticles block the entry of SARS-CoV-2 into cells

Decoy ACE2 nanoparticles block the entry of SARS-CoV-2 into cells

Exploring simultaneous and sequential COVID-19 vaccine candidate

Exploring simultaneous and sequential COVID-19 vaccine candidate

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.